Clinical trial
Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
NCT00180778 · Imperial College London, Other · Withdrawn
Key facts
| NCT number | NCT00180778 |
|---|---|
| Title | Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss |
| Official title | Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS |
| Lead sponsor | Imperial College London, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Antiphospholipid Syndrome |
| Intervention type | Drug |
| Interventions | Low dose steroids |
| Enrollment | 0 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 26, 2024 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: